| Date Filed | Type | Description |
| 07/10/2023 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,430 shares
@ $29.88, valued at
$42.7k
Exercised 5,957 options to buy
@ $0 |
|
| 06/30/2023 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 12,732 options to buy
@ $31.33, valued at
$398.9k
Granted 5,985 options to buy
@ $0 |
|
| 06/30/2023 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 18,903 shares
@ $26.45, valued at
$500k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 8,912 shares
@ $0 |
|
| 11/22/2021 |
3
| GAYNOR RICHARD (Director) has filed a Form 3 on Zai Lab Ltd |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 11,509 options to buy
@ $18.82, valued at
$216.6k
Granted 5,578 options to buy
@ $0 |
|
| 05/22/2020 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 12,823 options to buy
@ $16.85, valued at
$216.1k
Granted 6,104 options to buy
@ $0 |
|
| 05/06/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 210,410 shares
@ $0
Disposed/sold 58,005 options to buy
@ $10.2, valued at
$591.7k
Disposed/sold 105,000 options to buy
@ $6.13, valued at
$643.7k
Disposed/sold 155,373 options to buy
@ $2.65, valued at
$411.7k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0 |
|
| 12/09/2019 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 11,200 options to buy
@ $21.23, valued at
$237.8k
Granted 61,800 options to buy
@ $21.23, valued at
$1.3M
|
|
| 11/27/2019 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $1.3749, valued at
$27.5k
Sold 23,000 shares
@ $1.3144, valued at
$30.2k
Sold 22,322 shares
@ $1.2384, valued at
$27.6k
|
|
| 11/25/2019 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 09/24/2019 |
3
| GAYNOR RICHARD (Director) has filed a Form 3 on Alkermes plc. |
| 09/24/2019 |
3
| GAYNOR RICHARD (Director) has filed a Form 3 on Alkermes plc. |
| 03/01/2019 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 57,500 shares
@ $0
Granted 105,000 options to buy
@ $6.13, valued at
$643.7k
|
|
| 06/26/2018 |
3
| GAYNOR RICHARD (President of R&D) has filed a Form 3 on Neon Therapeutics, Inc. |